| |
Par Pharma buys back $30.8M in senior notes
Wed Nov 25 (AP)
Par Pharmaceuticals Cos. said Wednesday it bought $30.8 million in senior notes through a tender offer. Earlier this month, the company had offered to buy back up to $65 million in convertible senior notes due 2010.
|
|
Top-Ranked Analysts
|
Provided by StarMine
|
| | |
Locate Industry by Company
|
| Market Capitalization: | 10B | | Price
/ Earnings: | 47.8 | | Price
/ Book: | -8.1 | | Net
Profit Margin (mrq): | 4.6% | | Price
To Free Cash Flow (mrq): | 38.2 | | Return
on Equity: | 6.9% | | Total
Debt / Equity: | 0.0 | | Dividend
Yield: | 0.0% |
|